New Alzheimer's drug donanemab slows early stages of disease by 35%
New Alzheimer's drug donanemab slows early stages of disease by 35%
www.usatoday.com
Eli Lilly says new Alzheimer's drug donanemab slows early stages of disease by 35%
0 comments